世界のリーシュマニア症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Leishmaniasis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4421
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、リーシュマニア症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンチモン酸メグルミン、ペンタミジン、ヒドロキシアミジンスチルベン、アムホテリシンB）、用途別市場規模（内臓リーシュマニア症、皮膚リーシュマニア症）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・リーシュマニア症治療の市場動向
・企業の競争状況、市場シェア
・リーシュマニア症治療の種類別市場規模と予測2016-2027（アンチモン酸メグルミン、ペンタミジン、ヒドロキシアミジンスチルベン、アムホテリシンB）
・リーシュマニア症治療の用途別市場規模と予測2016-2027（内臓リーシュマニア症、皮膚リーシュマニア症）
・リーシュマニア症治療の北米市場規模2016-2027（アメリカ、カナダ）
・リーシュマニア症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・リーシュマニア症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・リーシュマニア症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・リーシュマニア症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck、iCo Therapeutics、AEterna Zentaris、AEterna Zentaris AG、Eurofins Advinus、Pieris Pharmaceuticals、Dafra Pharma）
・結論

A drug used to treat diseases caused by parasitic protozoa leishmania

Market Analysis and Insights: Global Leishmaniasis Treatment Market
The global Leishmaniasis Treatment market size is projected to reach US$ 137.9 million by 2027, from US$ 95 million in 2020, at a CAGR of 5.0% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Leishmaniasis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Leishmaniasis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Leishmaniasis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Leishmaniasis Treatment market.

Global Leishmaniasis Treatment Scope and Market Size
Leishmaniasis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Leishmaniasis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Meglumine Antimoniate
Pentamidine
Hydroxyl Amidine Stilbene
Amphotericin B

Segment by Application
Visceral Leishmaniasis
Cutaneous Leishmaniasis

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
iCo Therapeutics
AEterna Zentaris
AEterna Zentaris AG
Eurofins Advinus
Pieris Pharmaceuticals
Dafra Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leishmaniasis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Meglumine Antimoniate
1.2.3 Pentamidine
1.2.4 Hydroxyl Amidine Stilbene
1.2.5 Amphotericin B
1.3 Market by Application
1.3.1 Global Leishmaniasis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Visceral Leishmaniasis
1.3.3 Cutaneous Leishmaniasis
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Leishmaniasis Treatment Market Perspective (2016-2027)
2.2 Leishmaniasis Treatment Growth Trends by Regions
2.2.1 Leishmaniasis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Leishmaniasis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Leishmaniasis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Leishmaniasis Treatment Industry Dynamic
2.3.1 Leishmaniasis Treatment Market Trends
2.3.2 Leishmaniasis Treatment Market Drivers
2.3.3 Leishmaniasis Treatment Market Challenges
2.3.4 Leishmaniasis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Leishmaniasis Treatment Players by Revenue
3.1.1 Global Top Leishmaniasis Treatment Players by Revenue (2016-2021)
3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Leishmaniasis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Leishmaniasis Treatment Revenue
3.4 Global Leishmaniasis Treatment Market Concentration Ratio
3.4.1 Global Leishmaniasis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leishmaniasis Treatment Revenue in 2020
3.5 Leishmaniasis Treatment Key Players Head office and Area Served
3.6 Key Players Leishmaniasis Treatment Product Solution and Service
3.7 Date of Enter into Leishmaniasis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Leishmaniasis Treatment Breakdown Data by Type
4.1 Global Leishmaniasis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Leishmaniasis Treatment Forecasted Market Size by Type (2022-2027)

5 Leishmaniasis Treatment Breakdown Data by Application
5.1 Global Leishmaniasis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Leishmaniasis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Leishmaniasis Treatment Market Size (2016-2027)
6.2 North America Leishmaniasis Treatment Market Size by Type
6.2.1 North America Leishmaniasis Treatment Market Size by Type (2016-2021)
6.2.2 North America Leishmaniasis Treatment Market Size by Type (2022-2027)
6.2.3 North America Leishmaniasis Treatment Market Size by Type (2016-2027)
6.3 North America Leishmaniasis Treatment Market Size by Application
6.3.1 North America Leishmaniasis Treatment Market Size by Application (2016-2021)
6.3.2 North America Leishmaniasis Treatment Market Size by Application (2022-2027)
6.3.3 North America Leishmaniasis Treatment Market Size by Application (2016-2027)
6.4 North America Leishmaniasis Treatment Market Size by Country
6.4.1 North America Leishmaniasis Treatment Market Size by Country (2016-2021)
6.4.2 North America Leishmaniasis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Leishmaniasis Treatment Market Size (2016-2027)
7.2 Europe Leishmaniasis Treatment Market Size by Type
7.2.1 Europe Leishmaniasis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Leishmaniasis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Leishmaniasis Treatment Market Size by Type (2016-2027)
7.3 Europe Leishmaniasis Treatment Market Size by Application
7.3.1 Europe Leishmaniasis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Leishmaniasis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Leishmaniasis Treatment Market Size by Application (2016-2027)
7.4 Europe Leishmaniasis Treatment Market Size by Country
7.4.1 Europe Leishmaniasis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Leishmaniasis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Leishmaniasis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Leishmaniasis Treatment Market Size by Type
8.2.1 Asia-Pacific Leishmaniasis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Leishmaniasis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Leishmaniasis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Leishmaniasis Treatment Market Size by Application
8.3.1 Asia-Pacific Leishmaniasis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Leishmaniasis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Leishmaniasis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Leishmaniasis Treatment Market Size by Region
8.4.1 Asia-Pacific Leishmaniasis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Leishmaniasis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Leishmaniasis Treatment Market Size (2016-2027)
9.2 Latin America Leishmaniasis Treatment Market Size by Type
9.2.1 Latin America Leishmaniasis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Leishmaniasis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Leishmaniasis Treatment Market Size by Type (2016-2027)
9.3 Latin America Leishmaniasis Treatment Market Size by Application
9.3.1 Latin America Leishmaniasis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Leishmaniasis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Leishmaniasis Treatment Market Size by Application (2016-2027)
9.4 Latin America Leishmaniasis Treatment Market Size by Country
9.4.1 Latin America Leishmaniasis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Leishmaniasis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Leishmaniasis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Leishmaniasis Treatment Market Size by Type
10.2.1 Middle East & Africa Leishmaniasis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Leishmaniasis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Leishmaniasis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Leishmaniasis Treatment Market Size by Application
10.3.1 Middle East & Africa Leishmaniasis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Leishmaniasis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Leishmaniasis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Leishmaniasis Treatment Market Size by Country
10.4.1 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Leishmaniasis Treatment Introduction
11.1.4 Merck Revenue in Leishmaniasis Treatment Business (2016-2021)
11.1.5 Merck Recent Development
11.2 iCo Therapeutics
11.2.1 iCo Therapeutics Company Details
11.2.2 iCo Therapeutics Business Overview
11.2.3 iCo Therapeutics Leishmaniasis Treatment Introduction
11.2.4 iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2016-2021)
11.2.5 iCo Therapeutics Recent Development
11.3 AEterna Zentaris
11.3.1 AEterna Zentaris Company Details
11.3.2 AEterna Zentaris Business Overview
11.3.3 AEterna Zentaris Leishmaniasis Treatment Introduction
11.3.4 AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2016-2021)
11.3.5 AEterna Zentaris Recent Development
11.4 AEterna Zentaris AG
11.4.1 AEterna Zentaris AG Company Details
11.4.2 AEterna Zentaris AG Business Overview
11.4.3 AEterna Zentaris AG Leishmaniasis Treatment Introduction
11.4.4 AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2016-2021)
11.4.5 AEterna Zentaris AG Recent Development
11.5 Eurofins Advinus
11.5.1 Eurofins Advinus Company Details
11.5.2 Eurofins Advinus Business Overview
11.5.3 Eurofins Advinus Leishmaniasis Treatment Introduction
11.5.4 Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2016-2021)
11.5.5 Eurofins Advinus Recent Development
11.6 Pieris Pharmaceuticals
11.6.1 Pieris Pharmaceuticals Company Details
11.6.2 Pieris Pharmaceuticals Business Overview
11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Introduction
11.6.4 Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2016-2021)
11.6.5 Pieris Pharmaceuticals Recent Development
11.7 Dafra Pharma
11.7.1 Dafra Pharma Company Details
11.7.2 Dafra Pharma Business Overview
11.7.3 Dafra Pharma Leishmaniasis Treatment Introduction
11.7.4 Dafra Pharma Revenue in Leishmaniasis Treatment Business (2016-2021)
11.7.5 Dafra Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Leishmaniasis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Meglumine Antimoniate
Table 3. Key Players of Pentamidine
Table 4. Key Players of Hydroxyl Amidine Stilbene
Table 5. Key Players of Amphotericin B
Table 6. Global Leishmaniasis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Leishmaniasis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Leishmaniasis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Leishmaniasis Treatment Market Share by Regions (2016-2021)
Table 10. Global Leishmaniasis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Leishmaniasis Treatment Market Share by Regions (2022-2027)
Table 12. Leishmaniasis Treatment Market Trends
Table 13. Leishmaniasis Treatment Market Drivers
Table 14. Leishmaniasis Treatment Market Challenges
Table 15. Leishmaniasis Treatment Market Restraints
Table 16. Global Leishmaniasis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Leishmaniasis Treatment Market Share by Players (2016-2021)
Table 18. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leishmaniasis Treatment as of 2020)
Table 19. Ranking of Global Top Leishmaniasis Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Leishmaniasis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Leishmaniasis Treatment Product Solution and Service
Table 23. Date of Enter into Leishmaniasis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Leishmaniasis Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Leishmaniasis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Leishmaniasis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Leishmaniasis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Leishmaniasis Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Leishmaniasis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Leishmaniasis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Leishmaniasis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Leishmaniasis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Leishmaniasis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Leishmaniasis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Leishmaniasis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Leishmaniasis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Leishmaniasis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Leishmaniasis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Leishmaniasis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Leishmaniasis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Leishmaniasis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Leishmaniasis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Leishmaniasis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Leishmaniasis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Leishmaniasis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Leishmaniasis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Leishmaniasis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Leishmaniasis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Leishmaniasis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Leishmaniasis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Leishmaniasis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Leishmaniasis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Leishmaniasis Treatment Product
Table 66. Merck Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million)
Table 67. Merck Recent Development
Table 68. iCo Therapeutics Company Details
Table 69. iCo Therapeutics Business Overview
Table 70. iCo Therapeutics Leishmaniasis Treatment Product
Table 71. iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million)
Table 72. iCo Therapeutics Recent Development
Table 73. AEterna Zentaris Company Details
Table 74. AEterna Zentaris Business Overview
Table 75. AEterna Zentaris Leishmaniasis Treatment Product
Table 76. AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million)
Table 77. AEterna Zentaris Recent Development
Table 78. AEterna Zentaris AG Company Details
Table 79. AEterna Zentaris AG Business Overview
Table 80. AEterna Zentaris AG Leishmaniasis Treatment Product
Table 81. AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million)
Table 82. AEterna Zentaris AG Recent Development
Table 83. Eurofins Advinus Company Details
Table 84. Eurofins Advinus Business Overview
Table 85. Eurofins Advinus Leishmaniasis Treatment Product
Table 86. Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million)
Table 87. Eurofins Advinus Recent Development
Table 88. Pieris Pharmaceuticals Company Details
Table 89. Pieris Pharmaceuticals Business Overview
Table 90. Pieris Pharmaceuticals Leishmaniasis Treatment Product
Table 91. Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million)
Table 92. Pieris Pharmaceuticals Recent Development
Table 93. Dafra Pharma Company Details
Table 94. Dafra Pharma Business Overview
Table 95. Dafra Pharma Leishmaniasis Treatment Product
Table 96. Dafra Pharma Revenue in Leishmaniasis Treatment Business (2016-2021) & (US$ Million)
Table 97. Dafra Pharma Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leishmaniasis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Meglumine Antimoniate Features
Figure 3. Pentamidine Features
Figure 4. Hydroxyl Amidine Stilbene Features
Figure 5. Amphotericin B Features
Figure 6. Global Leishmaniasis Treatment Market Share by Application: 2020 VS 2027
Figure 7. Visceral Leishmaniasis Case Studies
Figure 8. Cutaneous Leishmaniasis Case Studies
Figure 9. Leishmaniasis Treatment Report Years Considered
Figure 10. Global Leishmaniasis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Leishmaniasis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Leishmaniasis Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Leishmaniasis Treatment Market Share by Regions (2022-2027)
Figure 14. Global Leishmaniasis Treatment Market Share by Players in 2020
Figure 15. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leishmaniasis Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Leishmaniasis Treatment Revenue in 2020
Figure 17. Global Leishmaniasis Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Leishmaniasis Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Leishmaniasis Treatment Market Share by Type (2016-2027)
Figure 21. North America Leishmaniasis Treatment Market Share by Application (2016-2027)
Figure 22. North America Leishmaniasis Treatment Market Share by Country (2016-2027)
Figure 23. United States Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Leishmaniasis Treatment Market Share by Type (2016-2027)
Figure 27. Europe Leishmaniasis Treatment Market Share by Application (2016-2027)
Figure 28. Europe Leishmaniasis Treatment Market Share by Country (2016-2027)
Figure 29. Germany Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Leishmaniasis Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Leishmaniasis Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Leishmaniasis Treatment Market Share by Region (2016-2027)
Figure 39. China Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Leishmaniasis Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Leishmaniasis Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Leishmaniasis Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Leishmaniasis Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Leishmaniasis Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Leishmaniasis Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Leishmaniasis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Merck Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021)
Figure 59. iCo Therapeutics Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021)
Figure 60. AEterna Zentaris Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021)
Figure 61. AEterna Zentaris AG Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021)
Figure 62. Eurofins Advinus Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021)
Figure 63. Pieris Pharmaceuticals Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021)
Figure 64. Dafra Pharma Revenue Growth Rate in Leishmaniasis Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の皮膚B細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous B-Cell Lymphoma Treatment Market The global Cutaneous B-Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and hig…
世界の皮膚放射線障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Radiation Injury Treatment Market The global Cutaneous Radiation Injury Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…
世界の皮膚肥満細胞症治療市場規模・現状・予測（2021年-2027年） Cutaneous mastocytosis is a form of mastocytosis that primarily affects the skin. There are three main forms of the condition: maculopapular cutaneous mastocytosis (also called urticaria pigmentosa), solitary cutaneous mastocytoma, and diffuse cutaneous mastocytosis. Market Analysis and Insights: Gl…
世界の皮膚エリテマトーデス（CLE）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Lupus Erythematosus (CLE) Treatment Market The global Cutaneous Lupus Erythematosus (CLE) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…
世界の皮膚扁平上皮がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Squamous Cell Carcinoma Treatment Market The global Cutaneous Squamous Cell Carcinoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …